About

Dr. Roy-Chaudhury currently leads a translational research program in uremic vascular biology funded through the National Institutes of Health, the Veterans Administration research program, and through industry grants. He has published over 175 papers, and is a sought after invited speaker, both nationally and internationally.

He has also been actively involved in the public policy and administrative aspects of dialysis vascular access care and hemodialysis as a previous or current board member/councilor/committee chair for the American Society of Diagnostic and Interventional Nephrology, the Renal Network, the Interventional Nephrology Advisory Group of the American Society of Nephrology (ASN), the ASN Board of Advisors and Capitol Hill advocacy team, the ASN Post Graduation Education Committee and the International Society of Nephrology-India and South Asia Committees, as well as being the previous President of the American Nephrologists of Indian Origin (ANIO).

Dr. Roy-Chaudhury was also the founding American Society of Nephrology co-chair of the Kidney Health Initiative, which is a public-private partnership between the ASN and the FDA, which aims to bring together nephrologists, industry partners, patient advocacy groups and regulatory agencies; in an attempt to facilitate the passage of drugs, devices and biologics into the kidney disease space. In 2019, he was elected to the ASN Council which is a nine member apex leadership body for the American Society of Nephrology which has over 18,000 members.